NCT00303394View on ClinicalTrials.gov

Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

IL-1Ra

Trial Locations (2)

2280

Steno Diabetes Center, Gentofte Municipality

8091

University Hospital of Zurich, Division of Endocrinology and Diabetes, Zurich

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

University of Zurich

OTHER

NCT00303394 - Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist | Biotech Hunter | Biotech Hunter